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2. Abstract 
Glycosylphosphatidylinositol (GPI) anchoring of proteins is an evolutionarily conserved 
post-translational modification. In mammalian cells, over 100 proteins are anchored by 
GPI to the cell surface. The biosynthesis of GPI is carried out in the ER, generating 
precursor of GPI-anchored proteins. Precursors then undergo structural remodeling of 
GPI to generate mature GPI-anchored proteins. The molecular mechanisms of the 
post-Golgi transport of GPI-anchored proteins are not well understood. For example, 
whether GPI-anchored proteins require transmembrane cargo receptors or not is still 
unresolved. To address these issue, I took advantage of forward genetic screening using 
human haploid cell line, HAP1 cell, and identified subunits of the Golgi-associated 
retrograde protein (GARP) complex, a tethering factor involved in endosome-to-TGN 
retrograde transport. Knockout (KO) of each of the four GARP subunits, VPS51-VPS54, 
in HEK293 cells caused severely defective anterograde transport of both GPI-anchored 
and transmembrane proteins from the TGN. Overexpression of VAMP4, v-SNARE, in 
VPS54-KO cells partially restored not only endosome-to-TGN retrograde transport, but 
also anterograde transport of both GPI-anchored and transmembrane proteins. Further 
screening for genes whose overexpression rescue the VPS54-KO phenotype identified 
TMEM87A, encoding an uncharacterized Golgi-resident membrane protein. 
Overexpression of TMEM87A or its close homologue TMEM87B in VPS54-KO cells 
partially restored endosome-to-TGN retrograde transport and anterograde transport. 
Therefore, post-Golgi anterograde transport is coupled with endosome-to-TGN 
retrograde transport for recycling of molecules critical for efficient post-Golgi 
anterograde transport of membrane proteins. In addition, TMEM87A and TMEM87B 
are involved in endosome-to-TGN retrograde transport.
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3. General introduction 
Protein trafficking in eukaryotic cells is mediated by bidirectional vesicular 
transport between cellular compartments (Brandizzi and Barlowe, 2013). Vesicular 
transport can be divided into two pathways: anterograde transport, which is the route 
from the ER to the plasma membrane, and retrograde transport, which is the opposite 
route. Each of these transport pathways consists of four steps; budding, movement, 
tethering, and uncoating and fusion (Bonifacino and Glick, 2004; Brandizzi and 
Barlowe, 2013). Anterograde transport from the ER to the ERGIC-Golgi is mediated by 
COPII-coated vesicles, and retrograde transport from the Golgi to the ER by 
COPI-coated vesicles. Abnormality of COPI-dependent retrograde transport from the 
ERGIC disrupts COPII-mediated anterograde transport from the ER since recycling of 
proteins, such as v-SNAREs and cargo receptors, is disturbed (Pepperkok et al., 1993; 
Peter et al., 1993). Therefore, protein recycling mediated by COPI-dependent retrograde 
transport is required for efficient anterograde transport from the ER. Anterograde and 
retrograde transport also take place between the TGN and the plasma membrane. Three 
retrograde transport pathways to the TGN have been identified: from early, recycling, or 
late endosomes (Chia et al., 2013). Fusion of endosome-derived retrograde carriers with 
the TGN membrane is mediated by SNARE complex assembly between v-SNARE, 
vesicle-associated membrane protein 4 (VAMP4), and the TGN-localized t-SNAREs, 
Syntaxin 6 (STX6), STX16 and Vti1 (Mallard et al., 2002; Hong and Lev, 2013). 
Retrograde transport to the TGN was first discovered through the transport routes of 
toxins (Mallard et al., 1998) and is now thought to act as a protein recycling route from 
endosomes.  
Glycosylphosphatidylinositol (GPI) anchoring of proteins is an evolutionarily 
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conserved post-translational modification (Kinoshita et al., 2008). In mammalian cells, 
over 100 proteins are anchored by GPI to the cell surface. GPI is a glycolipid composed 
of phosphatidylinositol, glucosamine, 3 mannoses (Mans) and 2 ethanolamine 
phosphates (EtNPs) and attached to the C-terminus of proteins (Fig. 1A). The 
biosynthesis of GPI is carried out in the ER, generating precursor of GPI-anchored 
proteins (GPI-APs) (Fig. 1B). The precursors are remodeled in their sugar and the lipid 
portion in the ER and the Golgi. The remodeling of GPI in the ER is carried out by 
post-GPI attachment to proteins 1 (PGAP1) and PGAP5 (Tanaka et al., 2004; Fujita et 
al., 2009). PGAP1 removes acyl chain linked to the inositol and PGAP5 removes EtNP 
on the 2nd Man (Fig. 1C). Remodeled GPI-APs are then accumulated in the ER exit site 
in the p24 family complex dependent manner, a cargo receptor of GPI-APs (Fujita et al., 
2011), and transported to the Golgi mediated by COPII vesicles (Fig. 1C). GPI-APs in 
the Golgi undergo fatty acid remodeling mediated by PGAP3 and PGAP2 (Tashima et 
al., 2006; Maeda et al., 2007). PGAP3 removes unsaturated fatty acid from the sn2 
position and PGAP2 is essential for addition of a saturated fatty acid, usually stearic 
acid, to the same position, resulting in mature GPI-APs (Fig. 1C). Lipid moiety of 
mature GPI-APs bearing saturated fatty acid chains is compatible with lipid 
microdomains, termed lipid-rafts that are enriched in glycoshingolipid and cholesterol. 
In fact, GPI-APs are major proteins in lipid-rafts.   
The molecular mechanisms for the anterograde transport of GPI-APs from the ER 
is relatively well understood. Because GPI-APs lack cytoplamic domain, they cannot 
directly bind to the COPII coat proteins and require transmembrane cargo receptors. A 
complex of p24 family proteins acts as a cargo receptor of GPI-APs by binding to them 
after they are remodeled by PGAP1 and PGAP5 and concentrates them into ER-exit site. 
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PGAP1- or PGAP5-defective mutant cells show delayed anterograde transport of 
GPI-APs due to a lack of efficient binding of GPI-APs with the p24 family complex 
(Fujita et al., 2011). p24 family of proteins were identified as components of COPI and 
COPII coated vesicles (Schimmoller et al., 1995; Belden and Barlowe, 1996). The p24 
proteins are type I transmembrane proteins conserved from yeast to mammals (Carney 
and Bowen, 2004). They have a Golgi dynamics (GOLD) domain and an α-helical 
region in the luminal side, a single-pass transmembrane domain and a short cytoplamic 
tail which contains binding motifs for the COPI and COPII coat proteins (Strating and 
Martens, 2009). Thus, p24 family complex can link GPI-APs to the COPII coat proteins, 
Sec24C or Sec24D (Bonnon et al., 2010).  
p24 family proteins are divided into 4 subfamilies, p24α, p24β, p24γ and p24δ 
(Dominguez et al., 1998). p24β and p24δ subfamilies have only one member, p24β1 
and p24δ1, respectively, whereas p24α subfamily have three members, p24α1-3 (α1 is 
pseudogene in human) and p24γ subfamily have five members, p24γ1-5. The p24 
family complex is composed of each one of 4 subfamilies though their stoichiometry 
has not been determined (Pastor-Cantizano et al., 2015). Knockdown (KD) of p24δ1 or 
p24γ2 disturbs the anterograde transport of GPI-APs from the ER (Takida et al., 2008; 
Theiler et al., 2014). Because KD of other p24γ subfamily members does not delay the 
anterograde transport of GPI-APs, the complex containing p24γ2 subunit is specifically 
required for sorting of GPI-APs (Theiler et al., 2014). A juxtamembrane α-helical 
region of p24γ2 subunit is required for the anterograde transport of GPI-APs, implying 
its role in binding GPI-anchor (Theiler et al., 2014).  
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4. Introduction of this thesis 
Previous studies showed that secretion of Wnt is dependent on endosome-to-TGN 
retrograde transport, based on the necessary recycling of its cargo receptor, wntless 
(Belenkaya et al., 2008; Franch-Marro et al., 2008; Harterink et al., 2011). These results 
highlighted the importance of protein recycling from endosomes. However, other 
studies showed that anterograde transport of thermosensitive vesicular stomatitis virus 
G protein (VSVGtsO45, hereafter VSVGts), which is more widely used as a model protein 
for testing anterograde transport, is not impaired in cells depleted of SNARE proteins 
involved in endosome-to-TGN retrograde transport (Choudhury et al., 2006; 
Nishimoto-Morita et al., 2009; Shitara et al., 2013). These results were quite different 
from the case of Wnt secretion and suggested that protein recycling to the TGN is less 
important for the anterograde transport of VSVGts. Therefore, the relevance of 
endosome-to-TGN retrograde transport in the post-Golgi anterograde transport is still 
controversial. 
Previously proposed molecular mechanisms of post-Golgi anterograde transport 
of GPI-APs are debatable. One is lipid based sorting. As GPI-anchor acts as a sorting 
signal for the apical membrane, most of GPI-APs are localized in the apical membrane 
surface. In addition of GPI-APs, specific lipids such as sphingolipids and cholesterol are 
enriched in the apical membrane (van Meer et al., 1987; Simons and van Meer, 1988). 
Consistent with this, depletion of sphingolipids and/or cholesterol impaired the apical 
sorting of GPI-APs (Paladino et al., 2004). However, this lipid based sorting model is 
still not consensus because GPI-APs with unsaturated fatty acid in PGAP3-defective 
mutant cells are transported to the plasma membrane with the similar kinetics to 
remodeled GPI-APs (Jaensch et al., 2014). Other proposed model is 
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oligomerization-dependent sorting. This model is based on the experiment that the 
impairment of oligomerization of GPI-APs resulted in the missorting to the basolateral 
membrane (Paladino et al., 2004; Paladino et al., 2007). This model, however, is also 
debatable. Because oligomerization of GPI-APs is impaired in PGAP3-defective mutant 
cells (Seong et al., 2013), transport efficiency of GPI-APs in PGAP3 mutant cells 
should be decreased. However, transport of GPI-APs is normal in PGAP3 mutant cells 
as described above (Jaensch et al., 2014). The third one is cargo receptor model. This 
model, however, has not been well studied because putative cargo receptors have not 
been identified yet. Thus, post-Golgi anterograde transport of GPI-APs requires 
transmembrane cargo receptors or not is still unresolved. 
In this study, I took advantage of forward genetic screening using human haploid 
cell line, HAP1 cells, to identify genes necessary for the efficient anterograde transport 
of GPI-APs and thereby identified genes encoding subunits of the Golgi-associated 
retrograde protein (GARP) complex. The GARP complex is a multi-subunit tethering 
factor localized in the TGN and involved in endosome-to-TGN retrograde transport 
(Bonifacino and Hierro, 2011). It is composed of four subunits, VPS51, VPS52, VPS53, 
and VPS54, each of which is essential for tethering (Conibear and Stevens, 2000; 
Siniossoglou and Pelham, 2002; Perez-Victoria et al., 2008; Perez-Victoria et al., 
2010a). I demonstrated that depletion of GARP complex causes delayed anterograde 
transport of proteins. Moreover, I performed screening of genes whose overexpression 
compensates the requirement of GARP complex and identified a gene, TMEM87A. 
TMEM87A is a multi-transmembrane protein and has a close homolog termed 
TMEM87B. The function of both TMEM87A and TMEM87B has not been reported. 
Here, I demonstrate that the GARP- and VAMP4-dependent endosome-to-TGN 
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retrograde transport is required for recycling of factors necessary for the efficient 
post-Golgi anterograde transport of cell-surface integral membrane proteins, such as 
GPI-anchored or transmembrane proteins. Also, TMEM87A and TMEM87B might be 
involved in the endosome-to-TGN retrograde transport. 
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5. Materials and methods 
Reagents and antibodies 
Lipofectamine 2000 and Lipofectamine RNAi MAX were purchased from Life 
Technologies. As primary antibodies, mouse monoclonal anti-CD59 (clone 5H8), 
anti-FLAG (clone M2), anti-HA (clone HA7) (Sigma-Aldrich), anti-STX6 (Stressgen), 
anti-α-tubulin, anti-Golgin97 (clone CDF4) (Life Technologies), anti-TMEM87A 
(clone #772807) (R&D systems), rabbit monoclonal anti-LAMP1 (clone D2D11) (Cell 
Signaling Technology), rabbit polyclonal anti-VPS53, VPS52 (kindly gifted from Drs. 
C. Schindler and J. S. Bonifacino (National Institutes of Health) (Perez-Victoria et al., 
2008), anti-GPP130 (Covance) and anti-EEA1 were used. The secondary antibodies 
were PE-conjugated goat anti-mouse IgG (Biolegend), Alexa Fluor 594-conjugated goat 
anti-mouse IgG, and Alexa Fluor 647-conjugated goat anti-mouse IgG (Life 
Technologies). Alexa Fluor 488-conjugated CTxB was purchased from Life 
Technologies. FITC-conjugated lectins were purchased from J-OIL MILLS. 
Plasmid construction 
A DNA fragment of VSVGex-FF-mEGFP-GPI (VFG-GPI), which encodes a GPI 
reporter protein, was amplified from pME-Neo2dH-VSVGex-FF-mEGFP-GPI (Maeda 
et al., 2008). The amplified fragment was cloned into the NotI and MluI sites of 
pRetroX-Tight-Pur (Clontech) using the In-fusion cloning reagents (Takara) to generate 
pRetroX-VFG-GPI-Pur. A DNA fragment of Flag-VSVGfull-EGFP (FVG-TM), 
encoding a transmembrane reporter protein, was amplified from 
pME-FLAG-VSVGfull-EGFP (Maeda et al., 2008). The amplified fragment was cloned 
into pRetroX-Tight-Pur using the same method as used to generate 
pRetroX-FVG-TM-Pur. A retroviral gene-trap vector containing an adenoviral splice 
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acceptor (SA) site, a PGK polyA signal, a PGK promoter (PGKpro), the blasticidin-S 
deaminase (BSD) gene, and human growth hormone (hGH) polyA was constructed as 
follows. The adenoviral SA site and hGH polyA sequence were amplified from 
pCMT-SAhygpA-NP21 (Genbank: AB609713) (Horie et al., 2011), which was kindly 
provided by Dr. Kyoji Horie (Nara Medical University). The primers (SA site) 
GTTCCTATTCTCTAGAAAGTATAGGAACTTCAGTG and 
ttGCGGCCGCTCAggTCAgTCAGAATTCCGGCGGCTAGCGATACCGTC, and 
(hGH polyA) ccTGAGCGGCCGCaaaaATCGATtCTGTGCCTTCTAGTTGCCAGC 
and TGGACCATCCTCTAGACTGCC were used in the amplification. The amplified 
fragments were cloned into pCMT-SAhygpA-NP21 at the two XbaI sites using the 
In-fusion cloning reagents, generating pCMT-SA. The PGK polyA and PGKpro 
sequences were amplified from pCMT-SAhygpA-NP21 using primers 
CTGACCTGAGCGGCCGCAGAAATTGATGATCTATTAAACAATAAAGA and 
ggtggACGCGTAGGTCGAAAGGCCCGGAGAT. The BSD gene was amplified from 
pLIB2-pgkBSD (Maeda et al., 2008) using primers 
acctACGCGTccaccATGCCTTTGTCTCAAGAAGAATC and 
GAAGGCACAGAATCGATTTAGCCCTCCCACACATAACC. The resulting PGK 
polyA-PGKpro and BSD fragments were cloned into the NotI and ClaI sites of 
pCMT-SA using In-fusion cloning reagents to generate pCMT-SApA-pgkBSD. The 
CRISPR/Cas9 expression plasmid, pX330 (Cong et al., 2013), was obtained from 
Addgene and used to generate pX330-hVPS51, -hVPS52, -hVPS53, -hVPS54#1, and 
-hVPS54#2; targeting sequences (described below) were cloned into pX330 plasmids 
digested with BbsI. To construct pX330-mEGFP plasmid, a PCR fragment amplified 
from a template plasmid, pME-(G4S)2-mEGFP, using primers 
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(gagaGGCCGGCCAaGCtAAgAAaAAgAAaATGACGCGTGGCGGAG and 
gagaGGCCGGCCTTcTTgGTtGCgGCaGGtCTcTTtccCTTGTACAGCTCGTCCA) 
was digested with FseI and cloned into the same site of pX330 vector. To generate 
pX330-mEGFP-hTMEM87A, -hTMEM87B#1 and -hTMEM87B#2, targeting 
sequences (described below) were cloned into pX330-mEGFP digested with BbsI. To 
express the GARP complex subunits, pEF6-BSD-VPS51, VPS52, VPS53, and 
mVPS54-V5-6His were kindly gifted by Drs. Juan Bonifacino and Chris Schindler 
(Perez-Victoria et al., 2008; Perez-Victoria et al., 2010b). To construct the 
corresponding expression plasmids, VAMP2, VAMP3, VAMP4, VAMP7, STX1A, and 
STX6 were PCR-amplified from a human brain cDNA library, and GPR107 and 
GPR108 from HeLa and Hep3B cell cDNA libraries, respectively. The products were 
cloned into pME-Zeo plasmid digested with EcoRI and NotI. TMEM87A and 
TMEM87B cDNAs were amplified from HeLa and Hep3B cell cDNA libraries, 
respectively, and inserted into pME-Zeo. To construct the N-terminally HA-tagged 
expression plasmids, TMEM87A and TMEM87B, except for their signal sequences (ss), 
were PCR-amplified and the XhoI- and NotI-digested products cloned into pME-ssHA 
plasmid, which harbors an ss derived from human CD59 upstream of the HA tag. To 
construct C-terminally 3×HA-tagged expression plasmids, TMEM87A and TMEM87B, 
except for their stop codons, were PCR-amplified and the products were cloned into 
XhoI- and MluI-digested pME-3xHA plasmid. To construct pLIB-BSD-VAMP4, 
pME-Zeo-VAMP4 was digested with EcoRI and NotI and cloned into pLIB-BSD 
digested with the same enzymes. Plasmid pLIB-BSD-ssHA-TMEM87A was 
constructed by PCR-amplifying a cDNA of ssHA-tagged TMEM87A, followed by 
digestion with SalI and NotI and cloning into pLIB2-BSD. To construct 
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pLIB-Hyg-RFP(S158T)-GPP34, pME-RFP(S158T)-GPP34 was digested with EcoRI 
and NotI and cloned into pLIB-Hyg.  
Establishment of HAP1FF9, HEK293FF6 and HEK293TM10 cells 
Retroviruses were produced in PLAT-GP packaging cells by cotransfection of the 
VSVG plasmid (pLC-VSVG) and pRetroX-Tet-On Advanced (Clontech) with 
pRetroX-VFG-GPI-Pur or pRetroX-FVG-TM-Pur. HAP1FF9 cells were established 
from HAP1 cells, kindly provided by Dr. Thijn R. Brummelkamp (Netherlands Cancer 
Institute) (Carette et al., 2011b). HAP1 cells were infected with retroviruses bearing 
pRetroX-VFG-GPI-Pur and pRetroX-Tet-On Advanced, followed by selection with 
puromycin and G418. A HAP1FF9 cell clone was obtained after limiting dilution and 
karyotype analysis. 
HEK293FF6 and HEK293TM10 cells were established from HEK293 cells by 
infection with retroviruses bearing pRetroX-Tet-On Advanced and 
pRetroX-VFG-GPI-Pur or pRetroX-FVG-TM-Pur, respectively, followed by selection 
with puromycin and G418, and limiting dilution. 
Cell culture 
HAP1FF9 cells were cultured in Iscove’s Modified Dulbecco’s Medium (IMDM) 
supplemented with 10% FCS, 600 µg/ml G418 and 6 µg/ml puromycin. HEK293FF6, 
HEK293TM10, GARP-KO cell lines, and TMEM87A and B double-KO (DKO) cell 
line established from HEK293FF6, were cultured in DMEM supplemented with 10% 
FCS, 600 µg/ml G418 and 1 µg/ml puromycin. V54KO cells stably expressing either 
empty vector, mVPS54-V5-His, hVAMP4, or ssHA-hTMEM87A (V54KO+Vec, 
V54KO+VPS54, V54KO+VAMP4, and V54KO+TM87A, respectively) were cultured 
in DMEM supplemented with 10% FCS, 600 µg/ml G418, 1 µg/ml puromycin and 10 
 14 
µg/ml blasticidin. V54KO+Vec and V54KO+VPS54 stably expressing 
RFP(S158T)-GPP34 were cultured in DMEM supplemented with 10% FCS, 600 µg/ml 
G418, 1 µg/ml puromycin, 10 µg/ml blasticidin, and 500 µg/ml hygromycin B. 
RFP(S158T)-GPP34, a fusion protein of enhanced RFP and TGN protein GPP34, is 
used as a TGN marker (Shaner et al., 2008). 
Enrichment of transport-delayed HAP1FF9 mutant cells 
A gene-trap virus was produced by transfection of PLAT-GP cells in eight 15-cm 
dishes using Lipofectamine 2000 and a mixture of pCMT-SApA-BSD and pLC-VSVG. 
The virus-containing supernatant was concentrated five times using PEG-it solution and 
then mixed with 8 µg/ml polybrene. HAP1FF9 cells (6 × 107 cells in total) prepared in 
6-well plates containing 2.5 × 106 cells per well were infected by centrifugation at 2,500 
rpm for 2 h at 32°C. Two days after infection, the cells were selected with 6 µg/ml 
blasticidin for 1 week. HAP1FF9 cells mutagenized by gene-trap vectors were cultured 
in medium containing 1 µg/ml Dox at 40°C for 24 h to induce and accumulate the 
VFG-GPI reporter protein in the ER (Maeda et al., 2008; Fujita et al., 2009). The cells 
were then quickly harvested with trypsin-EDTA and incubated in medium at 32°C for 
60 min, followed by staining with an M2 anti-Flag antibody and PE-conjugated goat 
anti-mouse IgG. Cells with decreased surface expression of the reporter protein were 
enriched twice by cell sorting using a FACSAria (BD Bioscience). 
Sequence analysis of the gene-trap insertion sites 
Genomic DNA was isolated from 3 × 107 cells using the Wizard Genomic DNA 
purification kit (Promega) according to the manufacturer’s protocol. Genomic DNA (15 
µg) was digested with HaeIII, followed by ligation with the splinkerette adaptor (Horie 
et al., 2011), which consists of two oligonucleotides: Spl-top-HaeIII 
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(CGAATCGTAACCGTTCGTACGAGAATTCGTACGAGAATCGCTGTCCTCTCC
AACGAGCCAAGG) and SplB-BLT-HaeIII 
(CCTTGGCTCGTTTTTTTTTGCAAAAA). After ligation, the DNA fragments were 
digested with PvuII, which cleaves the vector sequence between the 3′LTR and the 
upstream HaeIII site, to prevent unwanted vector amplification. After column 
purification, the fragments were used as templates for splinkerette PCR using the 
SPl-P1 primer (CGAATCGTAACCGTTCGTACGAGAA) and the first LTR primer 
(AGTGTATGTAAACTTCTGACCCACTGG). The resulting DNA fragments were 
further amplified by nested PCRs using the SPl-P2 primer 
(TCGTACGAGAATCGCTGTCCTCTCC) and the second LTR primer 
(CTTGTGTCATGCACAAAGTAGATGTCC) for the first PCR, Rd1Tru-LTR 
(ACACTCTTTCCCTACACGACGCTCTTCCGATCTGCTAGCTTGCCAAACCTAC
AGGTGGG), and Rd2Tru-Splink 
(GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCTGTCCTCTCCAACGAG
CCAAGG) for the second PCR. The underlined sequences indicate the Illumina 
sequencing primers. The resulting DNA products contained the end of the 5′LTR 
retroviral sequence followed by the genomic DNA sequence flanking the insertion site 
ending at the HaeIII restriction site and part of the splinkerette adaptor sequence. 
Illumina P5 (AATGATACGGCGACCACCG) and P7 
(CAAGCAGAAGACGGCATACGA) adapters and barcode sequences were attached to 
the products by 6 cycles of PCR with 10 ng of each of initial PCR product as the 
template. Paired-end sequencing (151-bp × 2) was performed on the MiSeq (Illumina) 
system. The numbers of reads obtained from control cells and Sort 2 cells were 
approximately 1.4 million and 1.2 million, respectively. 
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Analysis of gene-trap insertions 
FASTQ data files were analyzed using CLC Genomic Workbench software 
version 7.0.4 (CLC bio) according to a previously described method (Carette et al., 
2011a; Carette et al., 2011b). Briefly, after quality trimming and removal of the 
common LTR sequence, the 50-bp reads were mapped onto the human genome (hg19). 
To exclude ambiguous alignments, mismatch reads were not allowed and all 
non-specific matched reads were ignored. To eliminate PCR amplification bias and to 
determine the unique insertion sites, duplicate reads were removed and counted as one 
read (a unique insertion site). The independent insertion sites were further classified as 
being in the sense or antisense orientation compared to the gene. The total number of 
inactivating insertions, which consisted of all the sense or antisense orientations in the 
exons of the genes and the number of inactivating insertions per individual gene, were 
counted. The amount of enrichment of a particular gene in the screen was calculated by 
comparing the selected with the unselected population. For each gene, a P-value and a 
P-value corrected for the false-discovery rate (FDR) were calculated by the one-sided 
Fisher exact test using the R software. A bubble plot was created using R software. 
Establishment of knockout cell lines 
GARP-KO cell lines and TM87A, B-DKO cell lines were generated using the 
CRISPR-Cas9 system. For the generation of GARP-KO cell lines, HEK293FF6 cells 
were transiently transfected with pX330 plasmids bearing the targeting sequence for 
VPS51 (GGGAGGCTCCGGAGCGTCGG), VPS52 
(GGCCCGGGAACTGGTGTTGC), VPS53 (GCTCACGCCCGAGGTGCAGC) and 
VPS54 (#1; GAGGCACTGGTGAAGAACTG and #2; 
GGACACACATCTGGCAGTGA). After about 10 days of culture, cells with delayed 
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VFG-GPI transport were sorted using a FACS-Aria cell sorter. The collected population 
was subjected to limiting dilution. To generate TM87A, B-DKO cell lines, HEK293FF6 
cells were transiently transfected with pX330-mEGFP plasmids bearing the targeting 
sequence for hTMEM87A (GGAACAAACCTTACCTTTAT). After 3 days, cells with 
EGFP were sorted using a FACS-Aria cell sorter. The collected cells were subjected to 
limiting dilution. A clone, which had no wild-type allele, was picked up and used for 
next round knock out process. A TMEM87A KO cell line was transiently transfected 
with pX330-mEGFP plasmids bearing the either targeting sequence for hTMEM87B#1 
or #2 (#1; GCCGCCGCTGCTTTCCCGCC, #2; GACCCCGGCGGCTGTGCGCG). 
After cell sorting, collected cells were subjected to limiting dilution. DNA sequences 
were analyzed by the Sanger method. The DNA sequence of each KO cell line was 
listed in Table. 
Transport assay of reporter proteins using FACS 
The transport assay was conducted as previously described (Maeda et al., 2008; 
Fujita et al., 2009). Briefly, cells were cultured in medium supplemented with 1 µg/ml 
Dox at 40°C for 24 h, harvested using trypsin-EDTA (Sigma), and then incubated in 
complete medium at 32°C for the required time. The cells were stained with an M2 
anti-FLAG antibody and PE-conjugated goat anti-mouse IgG and then analyzed by 
FACS-CantoII (BD). For the KD experiments, 0.5 × 106 cells were transfected with 
siRNA oligonucleotides purchased from Life Technologies using the lipofectamine 
RNAi MAX reagent. Two days later, the cells were retransfected with the same siRNA 
oligos. On the following day, they were cultured in complete medium supplemented 
with 1 µg/ml Dox at 40°C for 24 h, after which transport was analyzed as described 
above. The siRNA sequences used were as follows: STX6#1: 
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(GCAACUGAAUUGAGUAUAATT, siRNA ID: s19959); STX6#2: 
(GCAGUUAUGUUGGAAGAUUTT, siRNA ID: s19960); VAMP4#1: 
(CAAACAACUUCGAAGGCAATT, siRNA ID: s16525); VAMP4#2: 
(GAUUUGGACCUAGAAAUGATT, siRNA ID: s16526). For the transient expression 
of FVG-TM, 0.5 × 106 cells were transfected with pME-FLAG-VSVGfull-EGFP using 
the Lipofectamine 2000 reagent. On the following day, the incubation temperature was 
shifted to 40°C for 48 h. If required, expression plasmids alone or together with 
pME-FLAG-VSVGfull-EGFP, were transfected into the cells described above.  
Western blotting 
Cell lysate was prepared by incubation in buffer containing 50 mM Tris-HCl 
(pH7.4), 150 mM NaCl, 1% Triton X-100, 5 mM EDTA and 1× protease inhibitor 
cocktail (Roche), followed by centrifugation at 15,000 rpm for 15 min. Supernatant was 
recovered, mixed with SDS sample buffer and boiled at 95 °C for 5 min. Samples were 
run on 10-20% SDS-PAGE gels and transferred to PVDF membranes. VPS52, VPS53, 
GAPDH, STX6 and α-tubulin were detected by anti-VPS52, anti-VPS53, anti-GAPDH, 
anti-STX6 and anti-α-tubulin antibodies.  
Quantitative reverse-transcription PCR (qRT-PCR) 
Total RNA was prepared using RNeasy mini kit (QIAGEN) and was used for 
generating cDNA by SuperScript VILO cDNA synthesis kit (LifeTechnologies). 
qRT-PCR was performed using SYBR Premix Ex Taq II (Tli RNase H plus) purchased 
from TaKaRa. The RNA expression was normalized by HPRT1 expression and the 
relative expression was calculated by ΔΔCT method. 
Immunofluorescence microscopy 
The cells were fixed with PBS containing 4% PFA for 20 min at room 
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temperature, followed by washing with 40 mM NH4Cl for 10 min. The cells were 
double-stained with anti-TMEM87A or anti-HA7 and anti-GPP130 antibody as the 
primary antibodies dissolved in staining buffer A1 (PBS containing 2.5% goat serum, 
0.1% NaN3, and 0.1% Triton X-100) followed by Alexa488-conjugated goat anti-mouse 
IgG and Alexa594-conjugated goat anti-rabbit IgG as the secondary antibodies in 
staining buffer A2 (PBS containing 1% BSA, 0.1% NaN3, and 0.1% Triton X-100). For 
intracellular localization of CD59, cells were pre-treated with 1 unit/ml PI-PLC (Life 
Technologies) for 1.5 h at 37°C. The cells were double-stained with anti-CD59 and 
anti-LAMP1 or anti-EEA1 dissolved in staining buffer B1 (PBS containing 2.5% goat 
serum, 0.1% NaN3, and 0.1% saponin) followed by the secondary antibodies as 
described above in staining buffer B2 (PBS containing 1% BSA, 0.1% NaN3, and 0.1% 
saponin). Confocal images were acquired on a FluoView FV1000 (Olympus). 
Flow cytometric analysis 
Cells were stained with anti-CD59 in FACS buffer (PBS containing 1% BSA, 0.1% 
NaN3) followed by staining with PE-conjugated goat anti-mouse IgG in FACS buffer. 
Surface glycosylation profiles were analyzed by FITC-conjugated lectins in FACS 
buffer containing 1 mM CaCl2, 1 mM MnCl2, and 1 mM MgCl2. 
Transport assay of reporter proteins based on immunofluorescence microscopy analysis 
Cells stably expressing RFP(S158T)-GPP34 were cultured in medium 
supplemented with 1 µg/ml Dox at 40°C for 24 h. On the following day, they were 
washed with cold PBS and chased with warmed complete medium at 32°C containing 
100 µg/ml cycloheximide (CHX) for the indicated time followed by fixation. For 
post-Golgi anterograde transport analysis, the cells were pre-cultured at 19°C for 3 h 
with complete medium containing 100 µg/ml CHX and then chased at 32°C. After 
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fixation, the cells were stained with M2 anti-FLAG antibody and Alexa647-conjugated 
goat anti-mouse IgG; the antibodies were dissolved in staining buffer without detergent. 
Images were obtained as described above. 
Retrograde transport assay of CTxB 
The cells were washed twice with PBS and then cultured in cold medium 
supplemented with 10 mM HEPES and 1 µg/ml Alexa488-conjugated CTxB for 30 min 
on ice. After incubation, the cells were washed with ice cold PBS once and incubated in 
warmed complete medium at 37°C for indicated time, followed by fixation and staining 
with combinations of anti-Golgin97 antibody dissolved in staining buffer A1 and 
Alexa594-conjugated goat anti-mouse IgG dissolved in staining buffer A2. Images were 
obtained as described above. 
Quantification of immunofluorescence images 
Fluorescence intensities were quantified using MetaMorph 3.0 (Molecular 
Devices). The VFG-GPI, CD59 or CTxB regions and the TGN (RFP-GPP34- or 
Golgin-97-positive regions), cell surface (FLAG positive regions) or lysosomes 
(LAMP1 positive regions) in each fluorescence image were assigned a threshold by 
MetaMorph 3.0. The fluorescence intensities of total VFG-GPI, CD59 or CTxB (I(t)) 
and VFG-GPI, CD59 or CTxB that colocalized with markers (I(m)) were measured and 
their ratios were expressed as the percentage of I(m) in I(t). Means and standard errors 
were calculated and plotted from 10 independent fluorescence images. 
Expression cloning 
A retroviral-based cDNA library from human brain was stably transfected into 
V54KO cells. Those cells with increased transport rate were sorted using a cell sorter. 
The culture and sorting steps were repeated once more. Genomic DNA was isolated 
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from pre-enrichment control cells and the sorted cells as described above. Genomic 
DNA (15 µg) was digested with Covaris S2 (M&S) using the 800-bp protocol, followed 
by repair of the ends of the products and ligation with the above-mentioned splinkerette 
adaptor. After ligation, the DNA fragments were used as templates for splinkerette PCR 
using the primers SPl-P2 and pLIB-F0 (CTCCCTTTATCCAGCCCTCACTCC). The 
resulting DNA fragments were further amplified by PCR using Rd1Tru-pLIB 
(ACACTCTTTCCCTACACGACGCTCTTCCGATCTCGCCGGAATTCGTTAGGCC
ATTA) and Rd2Tru-Splink 
(GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCTGTCCTCTCCAACGAG
CCAAGG). The underlined sequences indicate the Illumina sequencing primers. 
Illumina P5 and P7 adapters and barcode sequences were attached as described above 
and single-end sequencing (151-bp) was performed on the HiSeq2500 (Illumina) system.  
The numbers of reads obtained from control and the sorted cells were approximately 26 
million and 7.2 million, respectively. 
Sequence analysis of recovered cDNAs 
FASTQ data files were analyzed using CLC Genomic Workbench software version 
7.0.4. After quality trimming and removal of the common pLIB sequence, the reads 
were mapped to the human genome (hg19). For each gene, test statistics, a P-value, and 
the P-value corrected for the FDR of Kal’s Z-test were calculated by comparing the 
number of mapped reads using CLC Genomic Workbench software version 7.0.4 (Kal 
et al., 1999). 
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6. Results 
Screening mutant haploid cells defective in GPI-AP transport  
To identify genes necessary for the efficient anterograde transport of GPI-APs, I 
took advantage of forward genetic screening in human haploid cells, HAP1 cells 
(Carette et al., 2011b). Because gene function can be easily destroyed by one hit 
mutation in haploid cells, forward genetic screening can be applied to HAP1 cells. To 
monitor the anterograde transport of GPI-AP, a GPI-anchored reporter protein which 
was previously developed in genetic screening with CHO cells was used (Maeda et al., 
2008; Fujita et al., 2009). This reporter is a chimeric protein consisting of a luminal 
domain of VSVGts, a FLAG tag, an EGFP, and a C-terminal GPI attachment signal 
(VFG-GPI). VSVGts causes accumulation of the reporter in the ER at the restrictive 
temperature of 40°C, because of the unfolding status of VSVGts. In contrast, VSVGts 
can be rapidly folded at the permissive temperature of 32°C, which allows us to start 
transport of proteins synchronously. Therefore, transport status at x min after the 
temperature shift can be estimated by the ratio of surface arrived proteins (staining with 
anti-FLAG antibody under non-permeabilized conditions) to total one (fluorescence of 
EGFP) using flowcytometry. Thus, I first established a HAP1 cell line, HAP1FF9, with 
doxycycline (Dox)-inducible expression of VFG-GPI and mutagenized the cells using a 
retroviral gene-trapping vector. Control genomic DNA was extracted before the 
enrichment of transport mutants. Using a cell sorter, mutant cells showing slow GPI-AP 
transport, as determined by decreased surface levels of VFG-GPI, were collected 60 
min after the temperature shift. The collected cells were cultured and then resorted to 
enrich mutants with delayed GPI-AP transport (Sort 2, Fig. 2A). Retroviral insertion 
sites in the genomic DNA from Sort 2 cells and control pre-enrichment cells were 
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analyzed by deep sequencing. Enrichment rates were calculated for the respective genes 
by comparing the numbers of mapped independent-insertion sites of the respective gene 
between Sort 2 and control cells. The genes PGAP1 and PGAP5 (MPPE1), whose 
mutations have been known to cause delayed transport of GPI-APs, were enriched in 
Sort 2 (Fig. 2B), indicating the usefulness of the method. In addition, PGAP2 gene, 
which is required for the GPI fatty acid remodeling in the Golgi (Tashima et al., 2006), 
was also enriched in Sort 2. In the PGAP2 mutant cells, transport of GPI-APs is almost 
normal, but the surface expression of GPI-APs is greatly decreased because lyso form 
GPI-APs, the intermediate form during the fatty acid remodeling which harbors only 
single acyl-chain, are not reacylated due to PGAP2 defect and are released easily from 
the membrane into medium soon after arrival at the cell surface. 
 
Knockout of GARP complex subunits severely impairs anterograde transport of proteins 
Three genes, C11orf2 (also known as VPS51 or Ang2), VPS52, and VPS54, 
encoding subunits of the GARP complex, a tethering factor involved in 
endosome-to-TGN retrograde transport, were significantly enriched in Sort 2 cells 
(p<0.01) and the fourth subunit VPS53 was positioned close to the significance limit 
(Fig. 2B). In addition, COG8 gene encoding a subunit of conserved oligomeric Golgi 
(COG) complex, another multi-subunit tethering factor and involved in 
endosome-to-TGN retrograde transport, was highly enriched, suggesting 
endosome-to-TGN retrograde transport might be important for the anterograde transport 
of GPI-APs. To investigate whether the GARP complex is involved in the anterograde 
transport of GPI-APs, I generated GARP-KO cells using the CRISPR-Cas9 system 
(Cong et al., 2013; Mali et al., 2013) in HEK293FF6 cells, bearing Dox-inducible 
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VFG-GPI. All mutations caused frame-shifts (Table), indicating that all mutant cells 
had completely lost expression of the targeted genes. Indeed, VPS52 and VPS53 
proteins were nearly completely disappeared in V52KO and V53KO cells, respectively 
(Fig. 3A). To compare the kinetics of anterograde transport of VFG-GPI, I conducted a 
transport assay using HEK293FF6 wild-type or GARP-KO cells. The relative 
expression of VFG-GPI in each KO cell line (V51KO, V52KO, V53KO, and V54KO) 
90 min after the temperature shift was 14.7 ± 5.2%, 21.7 ± 11.0%, 5.9 ± 1.7%, and 27.0 
± 3.5%, respectively (mean ± SD, Figs. 3B and C), suggesting that the anterograde 
transport of GPI-APs is severely impaired in GARP-KO cells. To investigate whether 
delayed transport was specific to GPI-APs, I conducted a similar transport assay of a 
transmembrane type reporter protein in GARP-KO cells. The reporter protein, FVG-TM, 
was a chimeric protein consisting of a FLAG tag, VSVGts (full length), and EGFP 
(Maeda et al., 2008; Fujita et al., 2009). Because HEK293FF6 cell line does not have 
FVG-TM, its expression plasmid was transiently transfected into cells and its transport 
then assayed. After 90 min, the relative expression of FVG-TM in V51KO, V52KO, 
V53KO, and V54KO cells was only 3.7 ± 0.95%, 8.0 ± 2.5%, 2.4 ± 1.3%, and 18.6 ± 
7.0%, respectively (mean ± SD, Figs. 3D and E). Expression of the responsible gene in 
each KO cell restored the delayed transport of both VFG-GPI and FVG-TM (Fig. 3F), 
thus ruling out off-target effects. These results indicated that the GARP complex is 
required for the efficient anterograde transport of both GPI-anchored and 
transmembrane proteins. 
 
Post-Golgi anterograde transport is defective in V54KO cells 
To analyze which step of the transport is impaired in GARP KO cells, I performed 
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the transport assay using confocal microscopy in cells stably transfected with an empty 
vector or VPS54 (V54KO+Vec or V54KO+VPS54), together with RFP-GPP34 as a 
TGN marker. VFG-GPI was accumulated in the ER, followed by transport for indicated 
time after which the cells were fixed to terminate the transport. Ratios of VFG-GPI 
fluorescence intensity in the TGN to total cellular VFG-GPI fluorescence intensity were 
determined at each time point (Fig. 4B). In V54KO+VPS54 cells, the amount of 
VFG-GPI that reached the TGN increased for 20 min and gradually decreased at 90 min 
(Figs. 4A and B), suggesting that after VFG-GPI reached the TGN it was transported to 
the cell surface. In V54KO+Vec cells, the relative intensity in TGN was slightly 
increased at 20 min but it further increased for the next 60 min (Figs. 4A and B), 
suggesting that after its arrival at the TGN, VFG-GPI accumulated in the TGN for at 
least 60 min. This result suggested that KO of VPS54 causes impairment of post-Golgi 
transport. Although ER-to-Golgi transport appeared to be slightly affected in 
V54KO+Vec cells (0.15 ± 0.012 vs. 0.095 ± 0.0089 at 20 min; mean ± SEM), this 
might have been because of the indirect effect of delayed post-Golgi transport. To 
confirm that post-Golgi anterograde transport is impaired in V54KO cells, I analyzed 
the post-Golgi anterograde transport directly. It is known that post-Golgi anterograde 
transport can be reversibly arrested at 19°C (Matlin and Simons, 1983). After VFG-GPI 
was accumulate in the Golgi at 19°C, transport was chased for 45 min and VFG-GPI 
that reached cell surface was stained with anti-FLAG antibody under non-permeabilized 
conditions. Ratios of VFG-GPI fluorescence intensity in the cell surface to total cellular 
VFG-GPI fluorescence intensity were quantified (Fig. 4D). As shown in Fig. 4C, at 0 
min most of the VFG-GPI were localized in the TGN in both V54KO+VPS54 and 
V54KO+Vec cells. By 45 min, although a large amount of the VFG-GPI reached the 
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cell surface in V54KO+VPS54 cells (Figs. 4C and D), this was barely the case in 
V54KO+Vec cells, as VFG-GPI largely remained in the TGN (Figs. 4C and D). This 
result strongly pointed out the requirement of the GARP complex in post-Golgi 
anterograde transport.  
 
CD59, an endogenous GPI-AP, was missorted to lysosomes in V54KO cells  
The fact that post-Golgi anterograde transport was impaired in V54KO cells led 
me to investigate whether the cargo sorting at the TGN was impaired. To elucidate this 
point, intracellular localization of endogenous GPI-AP, CD59, was analyzed. To 
eliminate cell surface CD59, cells were treated with phosphatidylinositol-specific 
phospholipase C (PI-PLC) before fixation and analyzed by confocal microscopy 
because GPI-APs were specifically released from cell surface by PI-PLC. In 
V54KO+VPS54 cells, intracellular CD59 was hardly detectable whereas many CD59 
positive vesicles were observed in V54KO+Vec cells (Fig. 5A). These vesicles were 
largely colocalized with LAMP1, but not with EEA1 (Figs. 5A and B). This result 
suggested that CD59 was missorted to lysosomes in V54KO cells probably due to 
defective post-Golgi anterograde transport. If most of GPI-APs are missorted to 
lysosomes and degraded, it is possible that surface expression of GPI-APs is reduced. 
However, flow cytometric analysis revealed that surface expression of CD59 was not 
reduced in V54KO+Vec cells compared to V54KO+VPS54 cells (Fig. 5C), suggesting 
that the majority of GPI-APs are properly but slowly transported to the cell surface. 
 
GARP-KO caused abnormal O-glycosylation but not N-glycosylation 
Previous studies indicated that defective vesicular transport disrupted protein 
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glycosylation (Wu et al., 2004; Ong et al., 2014). Some congenital disorders of 
glycosylation are caused by the mutations in the subunits of COG complex (Wu et al., 
2004; Climer et al., 2015). Thus, I postulated that GARP deficiency might cause the 
abnormal glycosylation. To investigate this, I analyzed the surface glycosylation profile 
by fluorescent labeled lectins. The staining patterns of Con A, WGA, LCA, and MAM, 
all of them specifically bound to N-glycosylation, were not altered in V54KO+Vec cells 
(Fig. 6A), suggesting that GARP complex was not indispensable to N-glycosylation. In 
contrast, V54KO+Vec cells showed higher staining with SBA or PNA, and lower 
staining with UEA-I, all of them bound to O-glycosylation (Fig. 6A). As SBA or PNA 
bind to desialylated form of O-glycans, these results indicated the decreased sialylation 
efficiency in V54KO cells. The epitope of UEA-I is fucose linked to O-glycan, 
suggesting lower levels of fucosylation on O-glycans in V54KO cells. These results 
implied that GARP-KO specifically affected O-glycosylation but not N-glycosylation. 
To further examine this, I performed western blotting analysis. The molecular weight of 
TfR containing N-glycosylation only was not altered in V54KO+Vec or V53KO+Vec 
cell (Fig. 6B). In contrast, some of DAF or LAMP1 in V54KO+Vec or V53KO+Vec 
cells ran faster, both of them contained O-glycosylation (Fig. 6B). These results 
supported the notion that GARP complex is required for collect O-glycosylation but not 
N-glycosylation. To get an insight for surface glycolipid profile, I used bacterial toxin, 
cholera toxin B subunit (CTxB), which bound to GM1. The staining with CTxB was 
also decreased in V54KO+Vec cells (Fig. 6A), indicating lower surface expression of 
GM1. To investigate the intracellular localization of GM1, I stained GM1 with CTxB 
under pearmebilized conditions and analyzed by confocal microscopy. Most of GM1 
was localized in plasma membrane in V54KO+VPS54 cells whereas smaller amount of 
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GM1 was observed in plasma membrane but instead many intracellular pools were 
detectable in V54KO+Vec cells (Fig. 6C). These results indicated that GARP complex 
is involved in GM1 localization. 
 
VAMP4-mediated retrograde transport is required for recycling of proteins critical for 
efficient anterograde transport 
The GARP complex tethers endosome-derived transport carriers to the TGN, so 
endosome-to-TGN retrograde transport may contribute to post-Golgi anterograde 
transport by recycling the molecules involved. Thus, in V54KO cells less of these 
molecules, such as SNARE proteins, would be found in their expected location. If this 
is true, overexpression of SNAREs may restore the defective anterograde tansport in 
V54KO cells. To examine this possibility, several SNARE proteins localized in the 
post-Golgi compartments were overexpressed in V54KO cells and restoration of 
anterograde transport was then assessed. Overexpression of VAMP4 partially restored 
the delayed transport of both VFG-GPI and FVG-TM whereas overexpression of 
VAMP2, VAMP3, VAMP7, STX1A, or STX6 did not (Fig. 7). Because VAMP4 is 
involved in the endosome-to-TGN retrograde transport, I predicted to restore the 
defective endosome-to-TGN retrograde transport in V54KO cells. To investigate this 
possibility, I analyzed plasma membrane to TGN retrograde transport using CTxB as a 
cargo. I prepared V54KO cells stably expressing VAMP4 (V54KO+VAMP4) and 
collected cells that restored anterograde transport of VFG-GPI (Fig. 8A). To assess 
CTxB retrograde transport, Alexa488-conjugated CTxB was bound to the cell surface at 
4°C, after which cells were incubated at 37°C for 60 min to allow the transport of CTxB. 
Because CTxB binding to the cell surface was decreased in V54KO cells as described 
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above (Fig. 6A), retrograde transport efficiency was determined by comparing the ratio 
of Golgi-localized CTxB to total CTxB. The ratio of CTxB localized in the TGN at 60 
min in V54KO+Vec cells was lower than that in V54KO+VPS54 cells (Figs. 8B and C), 
indicating the impairment of endosome-to-TGN retrograde transport in V54KO cells, 
consistent with the findings of a previous study (Perez-Victoria et al., 2008). As shown 
in Figs.8B and C, the amount of TGN-localized CTxB at 60 min was clearly higher in 
V54KO+VAMP4 cells than in V54KO+Vec cells (0.21 ± 0.024 vs. 0.15 ± 0.016; mean 
± SEM). I interpreted this data that retrograde transport of CTxB was partially restored 
by VAMP4 overexpression and that the statistic insignificance (p=0.055) may be 
accounted for by the presence in V54KO+VAMP4 cells of a population that did not 
restore the anterograde transport (Fig. 8A). These results and those on the restoration of 
anterograde transport strongly indicated that VAMP4-mediated retrograde transport is 
important for the recycling of molecules involved in the anterograde transport of both 
GPI-anchored and transmembrane proteins. This conclusion was confirmed by using 
siRNA to abolish the expression of VAMP4 or STX6. For this experiment, we used a 
HEK293FF6 cell line for VFG-GPI transport and a HEK293TM10 cell line, in which 
expression of FVG-TM could be induced with Dox. As shown in Fig. 8D, both STX6 
and VAMP4 expression were efficiently knocked down. Depletion of VAMP4 or STX6 
impaired the anterograde transport of both VFG-GPI and FVG-TM (Fig. 8E). These 
results were consistent with the result from the VAMP4 overexpression experiments. 
These results supported an idea that post-Golgi anterograde transport was coupled with 
GARP- or VAMP4-dependent endosome-to-TGN retrograde transport. 
 
Potential role for TMEM87A and TMEM87B in endosome-to-TGN retrograde transport 
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In other words, some molecules required for the post-Golgi anterograde transport 
should be recycled back to the TGN in a GARP dependent manner. To identify such 
molecules, I performed the screening of genes whose overexpression can restore the 
delayed transport inV54KO cells. This is based on the idea that overproducing of the 
molecules can compensate the lack of molecules in the TGN in V54KO cells. A cDNA 
library derived from human brain was introduced into V54KO cells, and the cDNAs in 
the transport-restored cell populations were sequenced by next generation sequencer. 
From this screening, TMEM87A, encoding a multi-pass transmembrane protein 
belonging to the LU7TM family (from Uniprot), was obtained. Overexpression of 
TMEM87A partially restored the defect in anterograde transport of both VFG-GPI and 
FVG-TM in V54KO cells (Fig. 9A: Geometric means of cell surface levels of VFG-GPI 
and FVG-TM were 1.92±0.22 and 4.45±1.1 times, respectively, of those in 
V54KO+Vec (n=3)). Overexpression of TMEM87B, a close homolog of TMEM87A 
and a member of the same family, also restored the defect in V54KO cells (Fig. 9A: 
Geometric means of cell surface levels of VFG-GPI and FVG-TM were 1.85±0.22 and 
3.42±0.99 times, respectively, of those in V54KO+Vec (n=3)), suggesting its functional 
redundancy with TMEM87A. Recently, a role for GPR107—another LU7TM family 
member—was shown to be retrograde transport of toxins such as exotoxin A of 
Pseudomonas aeruginosa and ricin (Carette et al., 2011a; Elling et al., 2011; Tafesse et 
al., 2014; Zhou et al., 2014). Unlike TMEM87A and TMEM87B, overexpression of 
GPR107 or GPR108, a member of LU7TM family closely related to GPR107, did not 
restore the delayed transport of either VFG-GPI or FVG-TM in V54KO cells (Fig. 9B: 
Geometric means of cell surface levels of VFG-GPI and FVG-TM in V54KO+GPR107 
were 1.21±0.38 and 0.98±0.11 times, respectively, of those in V54KO+Vec (n=2); and 
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those in V54KO+GPR108 were 1.23±0.14 and 1.15±0.027 times, respectively, of those 
in V54KO+Vec (n=2)). These results suggested the specific function of TMEM87A and 
TMEM87B. Because these two proteins have not been characterized, I first investigated 
their localization in mammalian cells. Because endogenous TMEM87A protein could 
not be detected by immunoblotting and immunofluorescence analysis in HEK293 cells, 
expression plasmids of N-terminally HA-tagged or C-terminally 3×HA-tagged 
TMEM87A and TMEM87B were constructed and their functions were confirmed based 
on their ability to restore the V54KO phenotype. Overexpression of N- or C-terminally 
tagged TMEM87A restored the impairment of anterograde transport of VFG-GPI to an 
extent similar to that of the non-tagged version (data not shown), indicating that both 
HA-tagged TMEM87As were functional; by contrast, neither of the tagged TMEM87Bs 
were functional. Non-tagged or N- or C-terminally HA-tagged TMEM87A was 
transiently expressed in wild-type cells and the localization of the proteins was analyzed 
by confocal microscopy. As shown in Fig. 9C, non-tagged or N- or C-terminally 
HA-tagged TMEM87A predominantly colocalized with GPP130, indicating its Golgi 
localization.  
Because overexpression of TMEM87A or TMEM87B could restore the impaired 
anterograde transport of both GPI-anchored and transmembrane proteins, these proteins 
may not be specific cargo receptors for GPI-APs. So, I assumed that the mechanisms by 
which TMEM87A overexpression restored anterograde transport in V54KO cells was 
overcoming the impaired retrograde transport. To investigate this, I examined the 
retrograde transport of CTxB in TMEM87A-overexpressing cells. Thus, N-terminally 
HA-tagged TMEM87A was stably expressed in V54KO cells (V54KO+TM87A) and 
cells in which anterograde transport of VFG-GPI was partially restored were collected 
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(Fig. 9D). At 60 min, TGN-localized CTxB levels were significantly higher in 
V54KO+TM87A cells than in V54KO+Vec cells (Figs. 9E and F), which indicated that 
the V54KO phenotype could be restored by the restoration of retrograde transport in 
V54KO cells. Finally, I investigated whether a loss of TMEM87A and B affects 
retrograde transport of CTxB. For this, I generated TMEM87A and TMEM87B 
double-KO (TM87A, B-DKO) cell lines using HEK293 cells. HEK293 cells expressed 
both genes at levels comparable to VPS51 and VPS54 as assessed by qRT-PCR (Fig. 
10A). Contrary to my expectation, retrograde transport of CTxB was not affected in 
TM87A, B-DKO cell lines (data with clone #2 shown in Fig. 10B). It seemed that 
TMEM87A and B were not directly involved in retrograde transport of CTxB or that yet 
another protein is redundantly involved. It is, therefore, likely that overexpression of 
TMEM87A or B in V54KO cells enhanced retrograde transport efficiency in general. 
Taken together, our data provide evidence that TMEM87A and TMEM87B are 
Golgi-localized proteins involved in endosome-to-TGN retrograde transport. 
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7. Discussion 
The aim of this study was to identify genes necessary for the efficient anterograde 
transport of GPI-APs. Forward genetic screening using human haploid cell line 
identified genes encoding subunits of the GARP complex. Depletion of each component 
of this complex revealed its requirement in the anterograde transport of both 
GPI-anchored and transmembrane proteins. In V54KO cells, post-Golgi anterograde 
transport was severely delayed, consistent with localization of the GARP complex 
within the TGN (Perez-Victoria et al., 2008). The delay in anterograde transport in 
V54KO cells was partially restored by the overexpression of VAMP4, but not VAMP3, 
which also functions in endosome-to-TGN retrograde transport (Mallard et al., 2002). 
VAMP4 overexpression also repaired the endosome-to-TGN retrograde transport defect. 
According to these results, the defective anterograde transport in GARP-KO cells was 
caused by impaired endosome-to-TGN retrograde transport. Additionally, knockdown 
of VAMP4 or STX6 resulted in the defective anterograde transport of both 
GPI-anchored and transmembrane proteins. These results support a model in which 
endosome-to-TGN retrograde transport mediated by VAMP4 and GARP is required for 
recycling of molecules critical for post-Golgi anterograde transport (Fig. 11). Although 
the possibility that the GARP complex is directly involved in anterograde transport 
cannot be ruled out, this is unlikely because the overexpression of VAMP2, which 
forms a complex with plasma membrane-localized t-SNAREs and is required for the 
post-Golgi anterograde transport of proteins (Calakos et al., 1994; Olson et al., 1997; 
Chen and Scheller, 2001), could not restore delayed anterograde transport in V54KO 
cells (Fig. 7). 
Recently, it has been reported that members of GARP complex form another 
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protein complex, termed endosome-associated recycling protein (EARP), which is the 
multi-subunit tethering factor required for endocytic recycling (Schindler et al., 2015). 
In addition to VPS51, VPS52 and VPS53, EARP complex contains syndetin (also 
known as CCDC132 or VPS50) instead of VPS54. We produced VPS51, 52, 53, 54 KO 
cells. In the VPS51, 52 or 53 KO cells, both GARP and EARP functions would be 
impaired. In this study, however, VPS54 KO cells showed defects in anterograde 
protein transport from the Golgi, suggesting GARP function itself for tethering of 
endosome-derived vesicles to the Golgi is important for the transport.  
COG8 gene, encoding a subunit of COG complex, was identified in this 
screening (Fig. 2B). Similar to GARP complex, COG complex is a multi-subunit 
tethering factor composed of eight subunits (Ungar et al., 2006). COG complex acts as 
a tethering complex required for intra-Golgi or endosome-to-TGN retrograde transport 
(Oka et al., 2004; Laufman et al., 2011). Either one of these functions of COG or both 
might contribute to post-Golgi anterograde transport of integral membrane proteins.  
My results indicated that loss of GARP complex disturbed O-glycosylation, 
especially sialylation or fucosylation, but not N-glycosylation (Figs. 6A and B). It is 
interesting since specific defect in O-glycosylation has not been reported previously; for 
instance, loss of COG complex led to abnormal glycosylation of both N-glycosylation 
and O-glycosylation (Spaapen et al., 2005). Thus, I speculated that some 
glycosyltransferases for O-glycosylation transiently exited from the post-Golgi 
compartment and recycled back through endosomes in a GARP dependent manner. To 
confirm this, further analyses are needed. I also examined the surface expression of 
GM1 ganglioside and found the low expression of GM1 in V54KO cells (Fig. 6A). In 
contrast to low expression on cell surface, large amount of GM1 were detected as 
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intracellular pools in V54KO+Vec cells (Fig. 6C). Recent study suggested that GARP 
complex is involved in the lipid metabolism especially for sphingolipids and cholesterol 
(Frohlich et al., 2015). In VPS53 KD cells, cholesterol was highly accumulated in 
intracellular space (Frohlich et al., 2015) consistent with my observation of GM1 
localization in V54KO cells (Fig. 6C). Thus, I supposed that GARP dependent 
retrograde transport is required for not only collect protein glycosylation but also lipid 
homeostasis.   
Our results (Fig. 7 and Figs.8B and C) are consistent with previous reports 
showing that both tethering factors and SNAREs, especially v-SNAREs, contribute to 
vesicle docking and that overexpression of v-SNAREs compensates for tethering 
defects (VanRheenen et al., 1998; Wiederkehr et al., 2004; Laufman et al., 2011). As 
discussed by Laufman et al. (Laufman et al., 2011), overexpression of VAMP4 could 
bypass the requirement for tethering complexes (GARP in our case) because 
endosome-derived transport vesicles bearing highly concentrated v-SNARE proteins 
may directly interact with the t-SNARE complex, leading to their fusion (Laufman et al., 
2011). Unlike v-SNAREs, however, t-SNAREs have no such activity (Fig.7) (Laufman 
et al., 2011). There are at least three different t-SNARE complexes in the TGN or the 
Golgi, STX6-STX16-Vti1, STX10-STX16-Vti1, and STX5-Ykt6-GS28. Although 
distinct functions for these complexes have been proposed (Mallard et al., 2002; Tai et 
al., 2004; Ganley et al., 2008), there may be partial overlap such that the total amount of 
t-SNAREs is what allows vesicle tethering and fusion. Consistent with this speculation, 
the transport delay in cells with a knocked down STX6 was milder than in cells with a 
knocked down VAMP4 (Fig. 8E). 
In previous studies, knockdown of VAMP4 or STX6 did not cause delayed 
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anterograde transport of VSVGts (Choudhury et al., 2006; Shitara et al., 2013). 
However, I found that the anterograde transport of GPI-anchored and transmembrane 
reporter proteins was clearly affected by the KD of VAMP4 or STX6 (Fig. 8E). The 
discrepancy might be because of the different analytical methods; in the above-cited 
work, microscopy-based analyses were used to quantify transport efficiency whereas we 
used a flowcytometry-based transport assay. This allowed the simultaneous analysis of 
> 10,000 cells, in addition to being a more sensitive and quantitative method than 
microscopy. Therefore, flowcytometric analysis might be advantageous in the detection 
of small changes in transport efficiency, such as those seen with STX6 KD. 
Mutations in the GARP complex have been described in the literature. For 
example, the wobbler mouse, used as a model for amyotrophic lateral sclerosis, has a 
point mutation in VPS54, leading to neurodegeneration (Schmitt-John et al., 2005; 
Moser et al., 2013). The wobbler mutation causes VPS54 destabilization and leads to 
impaired endosome-to-TGN retrograde transport (Perez-Victoria et al., 2010a; Karlsson 
et al., 2013). However, the pathogenic mechanism is yet to be elucidated. More recently, 
mutations in VPS53 were identified in patients with progressive cerebello-cerebral 
atrophy type 2 (Feinstein et al., 2014). These patients display cerebellar and cerebral 
neuronal atrophy before the age of 1 year. The molecular mechanism leading to 
progressive cerebello-cerebral atrophy type 2 in patients carrying a mutation in VPS53 
is also not understood. Interestingly, despite the different phenotypes of VPS53 and 
VPS54 mutations, motor neurons are affected in both cases (Brunet and Sacher, 2014). 
In human, it was reported that mutations in genes involved in anterograde transport of 
proteins cause motor neuronal diseases (Maruyama et al., 2010; Novarino et al., 2014). 
This study revealed the importance of the GARP complex in the post-Golgi anterograde 
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transport of GPI-anchored and transmembrane proteins. In addition to the retrograde 
transport defect itself, defective anterograde transport resulting from inefficient protein 
recycling from the endosome to the TGN might contribute to the pathogenic mechanism 
of disorders caused by VPS53 and VPS54 mutations.  
I further screened genes whose overexpression restored delayed anterograde 
transport in V54KO cells to get specific cargo receptors for GPI-APs and identified an 
as yet uncharacterized gene, TMEM87A, encoding a member of the LU7TM family. 
Both TMEM87A and its close homologue TMEM87B restored delayed anterograde 
transport of both GPI-anchored and transmembrane proteins in V54KO cells, 
suggesting that they are functionally redundant and unfortunately not cargo receptors 
specific to GPI-APs. Microscopy analysis demonstrated the Golgi localization of 
TMEM87A, indicating its function at this site. This result is consistent with a previous 
report in which Ptm1p, the yeast homolog of TMEM87A, was identified in Tlg2p (yeast 
homolog of STX16)-containing compartments (Inadome et al., 2005). The retrograde 
transport of CTxB provided proof that endosome-to-TGN transport was partially 
restored in V54KO+TM87A cells. Thus, restoration of the V54KO phenotype by the 
overexpression of TMEM87A resulted from the restoration of retrograde transport in 
V54KO cells and suggested the involvement of TMEM87A in endosome-to-TGN 
retrograde transport (Fig. 11). Retrograde transport might be a common function of 
LU7TM family proteins, since it also shared by GPR107, another member of this family. 
However, my overexpression experiments (Figs. 9A and B) evidenced two functional 
subfamilies, such that TMEM87A/B and GPR107/108 might be involved in different 
retrograde transport pathways. 
Several questions regarding the precise functions of these LU7TM family 
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proteins and how these proteins are involved in retrograde transport remain unresolved. 
One possibility is that G-protein-coupled receptors (GPCRs) are needed to maintain 
Golgi homeostasis. In pharmacological studies, Golgi-localized Gβγ was shown to be 
required for post-Golgi anterograde transport (Stow et al., 1991; Irannejad and 
Wedegaertner, 2010). However, the GPCRs associated with Golgi-localized Gβγ are not 
known. Tafesse et al. proposed GPR107 as one such GPCR (Tafesse et al., 2014). In 
this study, TMEM87A/B modulated both endosome-to-TGN retrograde transport and 
post-Golgi anterograde transport. Thus, TMEM87A and TMEM87B are also good 
candidate GPCRs. Further studies are needed to elucidate the molecular function of 
these proteins. 
In conclusion, this study showed that GARP- and VAMP4-dependent 
endosome-to-TGN retrograde transport is required for recycling of molecules critical 
for the efficient post-Golgi anterograde transport of GPI-anchored and transmembrane 
proteins. GPI-APs lack a cytoplasmic domain, so their efficient transport probably relies 
on putative transmembrane cargo receptors. Identification of cargo receptors that 
recognize GPI-APs would confirm this molecular mechanism. 
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9. Figure legends 
Figure 1. Structure and biosynthesis of GPI-APs 
A. Structure of GPI-APs. Core structure of GPI is well conserved among species. GPI, 
composed of phosphatidylinositol, glucosamine, 3 mannoses, and 2 ethanolamine 
phosphates, is covalently linked to the C-terminus of proteins as a post-translational 
modification. GPI-APs are enriched in the lipid-rafts. B. Biosynthetic pathway of GPI. 
The biosynthesis of GPI is carried out in the ER through 11 stepwise reactions. After 
completion of assembly, GPI is covalently attached to the proteins by transamidation 
reaction, generating precursor of GPI-APs. C. Remodeling and transport pathway of 
GPI-APs. The precursor of GPI-APs generated in the ER are further remodeled in their 
sugar and lipid portions. In the ER, PGAP1 removes acyl chain linked to the inositol 
and PGAP5 removes ethanolamine phosphate attached to the 2nd mannose. These 
reactions are necessary for GPI-APs to bind to a p24 family complex, a cargo receptor. 
In the Golgi, PGAP3 removes unsaturated fatty acid from the sn2 position and PGAP2 
adds saturated fatty acid at the same position. 
 
Figure 2. Forward genetic screening of the factors required for the anterograde 
transport of GPI-APs. A. Enrichment of cells showing delayed VFG-GPI transport after 
two rounds of sorting. Transport assay of VFG-GPI in HAP1FF9 wild-type cells (left) 
and the cell population after sorting twice for delayed transport (right). B. Bubble plot 
of enriched gene-trap insertion numbers after two rounds of sorting. The significance of 
enrichment was calculated by comparing the numbers of insertions in each gene before 
and after two rounds of sorting and plotted. The horizontal line shows the chromosomal 
position of the genes, and the vertical line the significance of enrichment of each gene 
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(P value). The size of the bubble shows the number of inactivating insertion sites (IAIS). 
Genes significantly enriched in Sort 2 (P<0.01) are colored. Red bubbles indicated 
genes encoding the GARP complex subunits and green bubbles the genes involved in 
the remodeling of GPI-APs. The bubble of VPS53 indicated by arrow was close to the 
significance limit. 
 
Figure 3. Knockout (KO) of GARP complex subunits severely impairs the anterograde 
transport of proteins. A. Western blotting of VPS52 and VPS53 in HEK293FF6 
wild-type (WT), VPS52-KO (V52KO) and VPS53-KO (V53KO) cells, showing nearly 
complete reduction by specific KO. GAPDH was used as a loading control. B. 
Transport assay of VFG-GPI in WT and GARP-KO cells. Surface expression of 
VFG-GPI at the indicated time in WT and VPS54-KO (V54KO) cells was shown as an 
example. C. Relative transport of VFG-GPI in GARP-KO cells. The geometric mean 
fluorescence of surface VFG-GPI at each time point, determined from the histograms 
shown in (B), was plotted as a function of time, using the geometric mean of WT cells 
at 90 min as 100% relative transport. Data are the means of three independent 
experiments. Error bars represent the SDs (n=3). D. Transport assay of FVG-TM in WT 
and GARP-KO cells. WT and GARP-KO cells were transiently transfected with 
FVG-TM. Surface expression of FVG-TM at the indicated time in WT and V54KO 
cells was shown as an example. E. Relative transport of FVG-TM. The geometric mean 
fluorescence of surface FVG-TM, determined from the histograms shown in (D), was 
plotted similarly to (C). Data are the means of three independent experiments. Error 
bars represent the SDs (n=3). F. Rescue of transport delay in GARP-KO cells by the 
expression of the responsible genes. GARP-KO cells were transiently transfected with 
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VPS51, VPS52, VPS53, or VPS54 expression plasmid, after which the transport of 
VFG-GPI (left) was analyzed. For FVG-TM transport (right), cells were cotransfected 
with FVG-TM and indicated genes for rescue.  
 
Figure 4. Post-Golgi anterograde transport is defective in V54KO cells. A. VFG-GPI 
transport from the ER in V54KO or restored cells. Cells were cultured in medium 
containing 1 µg/ml Dox at 40°C for 24 h. VFG-GPI transport was chased at 32°C for 
the indicated time in medium containing 100 µg/ml CHX. Images at 0, 30, and 90 min 
are shown. Green, VFG-GPI; red, RFP-GPP34 as a TGN marker. Scale bars, 10 µm. B. 
The TGN localization of VFG-GPI was quantified based on (A). The ratio of the 
VFG-GPI intensity in the TGN to the total fluorescence intensity was determined. Data 
are the means of 10 independent images. Error bars represent the SEM (n=10). Similar 
results were obtained from two independent experiments. C. Post-Golgi transport of 
VFG-GPI in V54KO or restored cells. Cells cultured in medium containing 1 µg/ml 
Dox for 24 h at 40°C were pre-cultured in medium containing 100 µg/ml CHX for 3 h 
at 19°C; after which VFG-GPI transport was chased at 32°C for 0 or 45 min. To detect 
surface VFG-GPI, cells were stained with anti-FLAG M2 antibody under 
non-permeabilized conditions. Green, total expression of VFG-GPI; red, RFP-GPP34; 
cyan, surface expression of VFG-GPI. Scale bars, 10 µm. Similar results were obtained 
from two independent experiments. D. The ratio of surface arrived VFG-GPI was 
quantified based on (C). Data are the means of 10 independent images. Error bars 
represent the SEM (n=5). Similar results were obtained from two independent 
experiments.  
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Figure 5. Missorting of CD59 to lysosomes in V54KO cells. A. Intracellular 
localization of endogenous GPI-AP, CD59. Cells were treated with PI-PLC at 37°C for 
1.5 h after which fixed and double stained with anti-CD59 and anti-LAMP1 or 
anti-EEA1. Green, CD59; red, LAMP1 (upper panels) and EEA1 (lower panels) as 
lysosome and early-endosome markers, respectively. Scale bars, 10 µm. B. CD59 
localized in lysosomes was quantified from the images of (A). Data are the means of 10 
independent images. Error bars represent the SEM (n=10). Similar results were obtained 
in two independent experiments. C. Relative surface expression of CD59 in V54KO 
cells and restored cells. Surface expression of CD59 was analyzed by flowcytometry. 
The geometric mean fluorescence of surface CD59 in cells was quantified and relative 
expression was calculated. Error bars represent the SDs (n=2). 
 
Figure 6. Depletion of GARP complex impaired O-glycosylation but not 
N-glycosylation. A. Surface glycosylation profiles of V54KO cells. Cells were stained 
using FITC-conjugated lectins or Alexa Flour 488-conjugated CTxB and analyzed by 
flowcytometry. The geometric mean fluorescence was quantified for each probe and 
relative expression was calculated. Error bars represent the SDs (n=2 for Con A, n=3 for 
WGA, LCA, and MAM, and n=4 for SBA, PNA, UEA-I and CTxB). B. Western 
blotting of several glycoproteins in GARP-KO cells. TfR, DAF, and LAMP1 were 
detected. GAPDH was used as a loading control. Arrows represented abnormal 
glycosylation form of proteins. C. Confocal images with CTxB. Cells were fixed and 
double stained with CTxB and anti-GPP130 antibody under pearmeabilized conditions. 
Green, CTxB; red, GPP130 as a Golgi marker. Scale bars, 10 µm. 
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Figure 7. Overexpression of VAMP4 partially restored the anterograde defect in 
V54KO cells. Transport assay of VFG-GPI (left) and FVG-TM (right) in V54KO cells 
transiently transfected with the indicated genes. Surface expression levels of VFG-GPI 
and FVG-GPI at the indicated time were shown. 
 
Figure 8. VAMP4-dependent retrograde transport is required for recycling of proteins 
critical for the post-Golgi anterograde transport. A. Transport assay in V54KO cells 
stably expressing VAMP4 (V54KO+VAMP4). V54KO+VAMP4 cells in which the 
anterograde transport of VFG-GPI was efficiently restored were collected twice by cell 
sorting. After cell sorting, transport assay was conducted. B. Retrograde transport assay 
using CTxB. Cells incubated with Alexa Fluor 488-conjugated CTxB for 30 min on ice 
followed by a chase at 37°C for 0 or 60 min were analyzed by confocal microscopy 
after staining with anti-Golgin97 antibody. Green, CTxB; red, Golgin97 as a TGN 
marker. Scale bars, 10 µm. Similar results were obtained in two independent 
experiments. C. CTxB in the TGN was quantified. Data are the means of 10 
independent images. Error bars represent the SEM (n=10). Similar results were obtained 
in two independent experiments. D. Estimation of knockdown efficiency. HEK293FF6 
was transfected with indicated siRNAs and the expression of STX6 or VAMP4 were 
analyzed by Western blotting or qRT-PCR, respectively. For Western blotting, 
α-tubulin was used as a loading control. For qRT-PCR, HPRT1 was used as a control. 
#1 and #2 represent siRNAs targeting different sites. E. Effect of STX6 or VAMP4 
knockdown on anterograde transport. Transport assay of VFG-GPI (left) or FVG-TM 
(right) in HEK293FF6 or HEK293TM10 cells, respectively, transfected with indicated 
siRNAs. 
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Figure 9. Potential role for TMEM87A and TMEM87B in endosome-to-TGN 
retrograde transport. A. Overexpression of TMEM87A (TM87A) and TMEM87B 
(TM87B) partially rescued the delayed transport of proteins in V54KO cells. Transport 
assay of VFG-GPI (left) or FVG-TM (right) in V54KO cells transiently transfected with 
the indicated genes. B. Overexpression of GPR107 and GPR108 did not rescue delayed 
transport in V54KO cells. Transport assay of VFG-GPI (left) or FVG-TM (right) in 
V54KO cells transfected with the indicated genes. C. Subcellular localization of 
TM87A. Wild-type cells were transfected with non-tagged or HA-tagged TM87A and 
double-stained with anti-TMEM87A (non-tagged version) or anti-HA7 and 
anti-GPP130. Green, TMEM87A; red, GPP130 as a Golgi marker. Scale bars, 10 µm. D. 
Transport assay in V54KO cells stably expressing HA-TM87A (V54KO+TM87A). 
V54KO+TM87A in which the anterograde transport of VFG-GPI was efficiently 
restored were collected twice by cell sorting. After cell sorting, transport assay was 
conducted. E. CTxB retrograde transport at 0 min and 60 min. Green, CTxB; red, 
Golgin97. Scale bars, 10 µm. Similar results were obtained in two independent 
experiments. F. Quantitative data were obtained as described in Fig. 8C legend. Data are 
the means of 10 independent images. Error bars represent SEM (n=10). Similar results 
were obtained in two independent experiments.  
 
Figure 10. Double KO of TMEM87A and TMEM87B did not impair 
endosome-to-TGN retrograde tranposrt of CTxB. A. Relative expression of TMEM87A 
and B in wild-type HEK293 cells. The expression of TMEM87A and B relative to 
HPRT1 expression was analyzed by qRT-PCR. Both TMEM87A and B were express at 
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levels comparable to VPS51 and VPS54 in HEK293 cells. B. Retrograde transport assay 
in TMEM87A- and TMEM87B-double KO HEK293 cells using CTxB. CTxB 
retrograde transport at 0, 15, and 30 min in wild-type HEK293 cells and 
TMEM87A/B-double KO HEK293 cells were similar. 
 
Figure 11. Proposed model of the post-Golgi anterograde transport of proteins. 1. Cell 
surface integral membrane proteins are sorted and packaged in transport vesicles in a 
process mediated by putative cargo receptors. 2. The proteins are then transported to the 
plasma membrane together with the cargo receptors. 3. After dissociation of the proteins 
from the cargo receptors at the cell surface, the cargo receptors are endocytosed and 
delivered to early endosome (EE) or the recycling endosome (RE). 4. The cargo 
receptors are recycled back to the Golgi for further round of anterograde transport via 
endosome-to-TGN retrograde transport mediated by VAMP4, GARP complex and 
STX6. TMEM87A might be involved in this recycling step. 
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